126 related articles for article (PubMed ID: 15627485)
1. Quantitative structure-activity analyses of bufokinin and other tachykinins at bufokinin (bNK1) receptors of the small intestine of the cane toad, Bufo marinus.
Liu L; Murray M; Conlon JM; Burcher E
Biochem Pharmacol; 2005 Jan; 69(2):329-38. PubMed ID: 15627485
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity studies of bufokinin, substance P and their C-terminal fragments at bufokinin receptors in the small intestine of the cane toad, Bufo marinus.
Liu L; Murray M; Burcher E
Biochem Pharmacol; 2002 Jan; 63(2):217-24. PubMed ID: 11841796
[TBL] [Abstract][Full Text] [Related]
3. Pharmacological and biochemical investigation of receptors for the toad gut tachykinin peptide, bufokinin, in its species of origin.
Liu L; Warner FJ; Conlon JM; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):187-95. PubMed ID: 10494889
[TBL] [Abstract][Full Text] [Related]
4. Tachykinin receptors in the small intestine of the cane toad (Bufo marinus): a radioligand binding and functional study.
Burcher E; Warner FJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Jun; 357(6):692-700. PubMed ID: 9686947
[TBL] [Abstract][Full Text] [Related]
5. Characterization of receptors for two Xenopus gastrointestinal tachykinin peptides in their species of origin.
Johansson A; Liu L; Holmgren S; Burcher E
Naunyn Schmiedebergs Arch Pharmacol; 2004 Jul; 370(1):35-45. PubMed ID: 15235762
[TBL] [Abstract][Full Text] [Related]
6. Bufokinin: a substance P-related peptide from the gut of the toad, Bufo marinus with high binding affinity but low selectivity for mammalian tachykinin receptors.
Conlon JM; Warner FJ; Burcher E
J Pept Res; 1998 Mar; 51(3):210-5. PubMed ID: 9531424
[TBL] [Abstract][Full Text] [Related]
7. Molecular identification and characterization of three isoforms of tachykinin NK(1)-like receptors in the cane toad Bufo marinus.
Liu L; Markus I; Vandenberg RJ; Neilan BA; Murray M; Burcher E
Am J Physiol Regul Integr Comp Physiol; 2004 Sep; 287(3):R575-85. PubMed ID: 15155274
[TBL] [Abstract][Full Text] [Related]
8. Tachykinin peptides and receptors: putting amphibians into perspective.
Liu L; Burcher E
Peptides; 2005 Aug; 26(8):1369-82. PubMed ID: 16042977
[TBL] [Abstract][Full Text] [Related]
9. The primary structures and myotropic activities of two tachykinins isolated from the African clawed frog, Xenopus laevis.
Johansson A; Holmgren S; Conlon JM
Regul Pept; 2002 Oct; 108(2-3):113-21. PubMed ID: 12220734
[TBL] [Abstract][Full Text] [Related]
10. Bufokinin: immunoreactivity, receptor localization and actions in toad intestine and mesenteric circulation.
Liu L; Shang F; Perry MA; Comis A; Burcher E
Peptides; 2000 Sep; 21(9):1345-54. PubMed ID: 11072121
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of amphibian and mammalian tachykinins in the toad, Bufo marinus.
Courtice GP; Burcher E; Carlo-Stella R; Conlon JM
Neuropeptides; 1993 Mar; 24(3):171-6. PubMed ID: 7682677
[TBL] [Abstract][Full Text] [Related]
12. The role of the N-terminal and mid-region residues of substance P in regulating functional selectivity at the tachykinin NK1 receptor.
Perrine SA; Beard DJ; Young JK; Simmons MA
Eur J Pharmacol; 2008 Sep; 592(1-3):1-6. PubMed ID: 18634782
[TBL] [Abstract][Full Text] [Related]
13. Substitution of conserved glycine residue by alanine in natural and synthetic neuropeptide ligands causes partial agonism at the stomoxytachykinin receptor.
Poels J; Van Loy T; Franssens V; Detheux M; Nachman RJ; Oonk HB; Akerman KE; Vassart G; Parmentier M; De Loof A; Torfs H; Broeck JV
J Neurochem; 2004 Jul; 90(2):472-8. PubMed ID: 15228603
[TBL] [Abstract][Full Text] [Related]
14. Primary structures and effects on gastrointestinal motility of tachykinins from the rainbow trout.
Jensen J; Olson KR; Conlon JM
Am J Physiol; 1993 Oct; 265(4 Pt 2):R804-10. PubMed ID: 7694488
[TBL] [Abstract][Full Text] [Related]
15. Purification, characterization, and spasmogenic activity of neurotensin from the toad Bufo marinus.
Warner FJ; Burcher E; Carraway R; Conlon JM
Peptides; 1998; 19(7):1255-61. PubMed ID: 9786176
[TBL] [Abstract][Full Text] [Related]
16. Structure-activity relationships of arodyn, a novel acetylated kappa opioid receptor antagonist.
Bennett MA; Murray TF; Aldrich JV
J Pept Res; 2005 Mar; 65(3):322-32. PubMed ID: 15787962
[TBL] [Abstract][Full Text] [Related]
17. Tachykinins and tachykinin receptors in the gut, with special reference to NK2 receptors in human.
Lecci A; Capriati A; Altamura M; Maggi CA
Auton Neurosci; 2006 Jun; 126-127():232-49. PubMed ID: 16616700
[TBL] [Abstract][Full Text] [Related]
18. Kassina senegalensis skin tachykinins: molecular cloning of kassinin and (Thr2, Ile9)-kassinin biosynthetic precursor cDNAs and comparative bioactivity of mature tachykinins on the smooth muscle of rat urinary bladder.
Wang L; Zhou M; Lynch L; Chen T; Walker B; Shaw C
Biochimie; 2009 May; 91(5):613-9. PubMed ID: 19298842
[TBL] [Abstract][Full Text] [Related]
19. Functional selectivity of NK1 receptor signaling: peptide agonists can preferentially produce receptor activation or desensitization.
Simmons MA
J Pharmacol Exp Ther; 2006 Nov; 319(2):907-13. PubMed ID: 16916996
[TBL] [Abstract][Full Text] [Related]
20. Bufokinin: actions and distribution in the toad cardiovascular system.
Liu L; Shang F; Comis A; Burcher E
Clin Exp Pharmacol Physiol; 2000 Nov; 27(11):911-6. PubMed ID: 11071309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
